Beijing Hotgen Biotech Co.,Ltd. (688068.SH) announced that the company and its subsidiaries have recently obtained 5 domestic medical device registration certificates, 1 cosmetics registration, 1 authorized patent, and 1 computer software copyright. The acquisition of these qualifications has enriched the company's product portfolio, further improved the business areas of in vitro diagnostics and consumer products, enhanced the company's intellectual property protection system, facilitated the improvement of the company's market expansion capabilities, and strengthened the company's core competitiveness.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments